Financial Disclosure Statement

Robin Tuytten
Metabolomic Diagnostics

MSACL 2015 EU Abstract Title:
Preeclampsia Risk Stratification Early in Pregnancy: First Results of a New LC-MS Based Multiplex Metabolite Assay

DescriptionY/NSource
Grantsno
SalaryyesMetabolomic Diagnostics
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes